Connections >> December 2012
20 December 2012
Connections is MSFHR’s monthly e-newsletter. Each issue highlights the top MSFHR news from the past month and showcases the impact of research we’ve funded.
In this issue:
- Message from the President & CEO
- MSFHR-funded study looking at best dosing schedule for HPV vaccine
- Celebrating our partnership with St. Paul’s Hospital Foundation
- Connections readership survey – deadline extended
- Board chair Sue Paish named one of Canada’s Top 100 women
Message from the President & CEO
|MSFHR President & CEO Dr. Diane Finegood|
As 2012 draws to a close, I find myself looking back on my first ten months as the president and CEO of the Michael Smith Foundation for Health Research. The more I learn about MSFHR and its staff, the more I realize how privileged I am lead an organization that plays such a pivotal role in BC’s health research community. I continue to be impressed by the dedication and creativity shown by our staff and I’m excited by the work we are undertaking in collaboration with our various partners and stakeholders in government, health care, and academia.
With all that is going on, we haven’t lost sight of the fundamentals. We conducted a successful scholar award competition this year, and for the first time three of the scholars were co-funded by partners. Our next trainee competition for post-doctoral fellows will launch early in the new year. We recognize how important these awards are to keeping talented researchers in BC and building a vibrant research community.
I hope you enjoy time with family and friends over the holidays, and I look forward to working with many of you in the coming year.
Diane Finegood, PhD
President and CEO
Michael Smith Foundation for Health Research
MSFHR-funded study looking at best dosing schedule for HPV vaccine
An MSFHR-supported study is seeking 8,666 teenage girls across the country to help determine whether two or three doses of the vaccine Gardasil provide similar protection against human papillomavirus (HPV). HPV infections cause nearly all cases of cervical cancer, which is the second most commonly diagnosed cancer in women worldwide.
The study is part of a long-term HPV vaccine evaluation project. It builds on earlier research funded by MSFHR at the request of the provincial health officer that demonstrated the effectiveness of a two-dose vaccine regimen in conferring immunity.
Celebrating our partnership with St. Paul’s Hospital Foundation
On December 12, MSFHR and the St. Paul’s Hospital Foundation celebrated a new partnership between the two organizations.
The new collaboration, negotiated with the help of the Providence Health Care Research Institute, will jointly fund Scholar awards for Drs. Kora DeBeck and Art Poon, both affiliated with the BC Centre for Excellence in HIV/AIDS (BC-CfE). These awards build on a long tradition of MSFHR support for BC-CfE researchers, support that has put the BC-CfE at the forefront of a global effort to confront HIV/AIDS.
Connections readership survey – deadline extended
The deadline for completing our Connections readership survey has been extended to January 11, 2013.
This is your opportunity to help us refine our newsletter and ensure we’re offering stories you want to read in the coming year. To show our appreciation, we will draw for five $10 Starbucks cards. To enter the draw, follow the instructions at the end of the survey. Your contact information is collected separately to ensure survey responses are anonymous.
Board chair Sue Paish named one of Canada’s Top 100 women
Sue Paish, chair of the MSFHR Board of Directors, has been inducted into the Women’s Executive Network Hall of Fame.
The award recognizes those who have been named three times to the Women’s Executive Network list of of Canada’s 100 Most Powerful Women. Each year, these awards celebrate the professional achievements of women across the country in the private, public and not-for-profit sectors.